Anonymous ID: f417c7 Jan. 30, 2024, 8:05 a.m. No.20329708   🗄️.is 🔗kun   >>9725 >>9733 >>9852

https://newsroom.uw.edu/news-releases/timing-number-of-covid-shots-affect-newborn-protection

 

Timing, number of COVID shots affect newborn protection

In a study of mothers, total vaccinations and recency of the last dose were associated with a difference in cord-blood antibodies.

 

placenta to the fetus.

Mothers who want their newborns to have the highest levels of antibodies should receive their last vaccine dose during pregnancy. And they should receive more than the baseline two vaccinations against the disease, according to a study published today in JAMA Network Open.

 

Even babies born prematurely can benefit from the maternal COVID-19 vaccines, the findings showed.

 

The UW Medicine-led study examined the maternal and umbilical cord blood in 220 pregnancies involving Seattle-area individuals who had never tested positive for COVID-19. The researchers compared the antibodies in the samples, noting the date of the participants’ most recent COVID-19 vaccination and the total COVID shots each mother had received before the baby’s delivery. Participants gave birth at UW Medicine hospitals between Feb. 1, 2021, and Jan. 31, 2023.

 

Researchers found that the pregnant individuals who had three or more COVID-19 vaccine shots, including those who had the last shot closer to their delivery date, had about 10 times the amount of vaccine-specific antibodies in their blood and the baby’s cord blood at birth.

 

When the COVID-19 vaccine is administered during pregnancy, the antibodies the mother makes in response to the vaccine are transferred through the placenta to the fetus, the paper noted.

 

“In the absence of a prior COVID-19 infection, having three or more shots seems to improve the maternal antibody concentrations within the baby,” said Dr. Alisa Kachikis, a UW Medicine maternal-fetal medicine specialist and the study’s lead author. “The other takeaway is that even if it’s a preterm birth, having more doses and having those doses closer to the birth date will increase antibody concentrations.”

 

Kachikis suggested that the best protection is afforded to prospective mothers who receive more than two COVID-19 vaccinations and who receive their most recent dose during pregnancy.

 

“There was no difference in the concentration of antibodies between babies who were born preterm and term, if you control for how many vaccine doses the pregnant persons received and the timing of vaccines prior for delivery,” Kachikis noted.

 

In all, 36 mothers delivered preterm (median gestation of 35 weeks) and 184 delivered at full term (39 weeks). The study participants’ average age was 34 years. Before delivery, 121 of the participants received two doses of the COVID-19 vaccine and 99 received three or more doses.

 

The authors noted that, while much research to date has focused on the importance of getting vaccinated against COVID-19 during pregnancy, few studies have looked at the presence of antibodies when comparing preterm and term births, or at the impact of the number or timing of shots.

 

The study was supported by a grant from the National Institute of Allergies and Infectious Diseases (K23 A1153390).

Anonymous ID: f417c7 Jan. 30, 2024, 8:08 a.m. No.20329725   🗄️.is 🔗kun   >>9733

>>20329708

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814091

 

Abstract

Importance COVID-19 vaccine–derived antibodies in pregnant people may protect infants from severe infection in the first 6 months of life via transplacental antibody transfer. Few data exist on maternally derived SARS-CoV-2 antibodies in preterm compared with full-term infants in association with vaccination timing.

 

Objective To compare SARS-CoV-2 anti-Spike (anti-S) antibody levels in preterm and full-term infants in the context of vaccine dose timing before delivery.

 

Design, Setting, and Participants This prospective cohort study enrolled pregnant individuals and collected paired maternal and cord blood samples at delivery at the University of Washington between February 1, 2021, and January 31, 2023. Participants who had received at least 2 doses of a messenger RNA COVID-19 vaccine before delivery and did not have a history of prior COVID-19 infection or detectable anti–SARS-CoV-2 nucleocapsid antibodies were included.

 

Exposures Timing of the last vaccine dose and preterm or full-term gestational age at delivery.

Anonymous ID: f417c7 Jan. 30, 2024, 8:59 a.m. No.20329994   🗄️.is 🔗kun   >>0006 >>0018 >>0069 >>0420 >>0493

https://twitter.com/RepThomasMassie/status/1748385453760217324

 

Thomas Massie

@RepThomasMassie

Your primary care provider was bribed to get you to take the jab.

 

“Oh, but Congressman Massie, these were incentive payments, not bribes.”🤫

 

As always, follow the money.

10:42 AM · Jan 19, 2024

·

Anonymous ID: f417c7 Jan. 30, 2024, 9 a.m. No.20330006   🗄️.is 🔗kun   >>0018 >>0066

>>20329994

https://twitter.com/P_McCulloughMD/status/1748387579689595336

 

Peter A. McCullough, MD, MPH®

@P_McCulloughMD

Who funded Anthem BCBS to do this incentive program? COVID-19 vaccination caused record injuries and disabilities necessitating insurance payouts for diagnostic tests, hospitalizations, and therapeutics. Wonder if any executive would have the courage to speak out?

10:50 AM · Jan 19, 2024

·

Anonymous ID: f417c7 Jan. 30, 2024, 9:02 a.m. No.20330018   🗄️.is 🔗kun

>>20329994

>>20330006

 

Grant Taylor

@grantltaylor

Financial Incentives To Inject As Many Babies As Possible + VR Vaccine?

 

BCBS program specifies that every patient under the age of 2 that receives the [currently] prescribed 24 inoculations is worth a $400 payout to that doctor.

 

BCBS requires that a doctor must vaccinate 63% of their patients in order to qualify.

 

@gregreese

0:03 / 3:47

4:02 PM · Oct 26, 2023

 

https://twitter.com/grantltaylor/status/1717647806746317097

Anonymous ID: f417c7 Jan. 30, 2024, 9:04 a.m. No.20330024   🗄️.is 🔗kun

https://www.cnbc.com/2024/01/30/ups-reports-drop-in-package-volume-stock-tumbles.html

 

UPS announces 12,000 job cuts, says package volume slipped last quarter

 

UPS fell short of Wall Street revenue estimates Tuesday, reporting drops in shipping volume, both internationally and domestically, in its fourth-quarter earnings report. The company also announced 12,000 layoffs as part of an effort to align resources in 2024.

 

The workforce reductions will save the company about $1 billion in costs, CEO Carol Tomé said on a company earnings call.

 

“2023 was a unique, and quite candidly, difficult and disappointing year. We experienced declines in volume, revenue and operating profits and all three of our business segments,” Tomé said.

 

Shares of the package giant dipped 8% in early trading.

 

Here’s how the company performed compared to Wall Street estimates:

 

Adjusted earnings: $2.47 vs. $2.46 per share expected, according to LSEG, formerly known as Refinitiv

Revenue: $24.92 billion vs. $25.43 billion expected

For the last three months of 2023, UPS reported net income of $1.61 billion, or $1.87 per share, compared with $3.45 billion, or $3.96 per share, a year earlier. Adjusting for one-time items related to pensions and intangible assets, UPS earned $2.47 per share.

 

Revenue declined 7.8% to $24.9 billion from $27 billion last year.

 

The company reported a 7.4% drop in average daily volume domestically and an 8.3% decrease internationally. Tomé said the international softness was “heavily weighted” in Europe, coupled with freight complications in the Red Sea region, as well as the Panama and Suez canals.

 

Though the earnings report did not directly mention any financial impacts from negotiations with the Teamsters in August over labor contracts, Tomé cited the talks and the macroeconomic environment more broadly as contributing to the “disappointing” year.

 

The company also said it’s considering selling its Coyote truck brokerage business, which Tomé called a “highly cyclical” business with “considerable earnings volatility.” The CEO also added that the company is planning to ask workers to return to the office five days a week in 2024.

 

UPS’ 2024 outlook expects revenue to range from $92 billion to $94.5 billion, with an adjusted operating margin of about 10% to 10.6%.

 

Don’t miss these stories from CNBC PRO:

Anonymous ID: f417c7 Jan. 30, 2024, 9:05 a.m. No.20330030   🗄️.is 🔗kun

Tommy 🇬🇧

@TG_81

Should you be allowed to stand as an MP if you can't speak English? 🤔

From

Afzal Khan MP

3:56 AM · Jan 30, 2024

 

https://twitter.com/TG_81/status/1752269568309879295

Anonymous ID: f417c7 Jan. 30, 2024, 9:06 a.m. No.20330033   🗄️.is 🔗kun   >>0069 >>0363 >>0420 >>0493

https://twitter.com/MarioNawfal/status/1752363986266288329

 

Mario Nawfal

 

@MarioNawfal

🚨 BREAKING: RUSSIA CONSIDERS SENDING NUKES TO CUBA | FIRST TIME IN 62 YEARS

 

Moscow is reportedly considering sending Nuclear Weapons to Cuba - it would be the first time since the Cuban Missile Crisis in 1962.

 

Is this in response to the U.S. sending nukes to the UK?

 

Sources: Sky News

Quote

Mario Nawfal

 

@MarioNawfal

·

Jan 26

🇺🇸 U.S. NUCLEAR WEAPONS ARRIVING SOON IN THE UK

 

Pentagon documents revealed the U.S. has prepared several strategic nuclear warheads for shipment to the UK, marking the first such transfer in 15 years.

 

Moscow has issued a warning of 'escalation' as these warheads are set to be… twitter.com/MarioNawfal/st…

Show more

Last edited

10:11 AM · Jan 30, 2024

·

Anonymous ID: f417c7 Jan. 30, 2024, 9:26 a.m. No.20330117   🗄️.is 🔗kun   >>0211

>>20330066

>Some people conspired to.

>Create the mRNA/LNP dangerous platform/protocol

 

Yes, the US Government and Us Military via DARPA in 2013, via contractors including Pfizer and Moderna.

 

darpa 2017…

 

https://www.darpa.mil/news-events/2017-02-06a

 

Removing the Viral Threat: Two Months to Stop Pandemic X from Taking Hold(2017)

 

darpa aims to develop an integrated end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in sixty days or less

 

darpa contracted Moderna, Pfizer, etc in 2013 to craft MRNA gene editing technologies for future, unknown pandemics….

 

https://investors.modernatx.com/news/news-details/2013/darpa-awards-Moderna-Therapeutics-a-Grant-for-up-to-25-Million-to-Develop-Messenger-RNA-Therapeutics/default.aspx

 

https://money.yahoo.com/2013-12-05-darpa-hires-pfizer-to-perform-groundbreaking-vacci.html

 

https://news.clearancejobs.com/2013/12/04/pfizer-awarded-darpa-biodefense-contract-dod-daily-contracts/

 

https://phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf

 

Not only has all of this been a long time in the making, and MANY presidents and darpa heads, and 'lawmakers' have been in the know for many years, but the initial viral research AND the follow up jabs are built to spec as ordered by the US Mil/DOD via darpa. And the face of the rollouts was the director of the NIH and the lion's share of US HIV/AIDS 'research, Fauci.

 

Wuhan & Harvard's Charles Lieber

Charles Lieber Inventions, Patents and Patent Applications - Justia Patents Search

 

https://patents.justia.com/inventor/charles-lieber

 

Bioelectronics & Trump's Warp Speed head Moncef Slaoui

https://en.wikipedia.org/wiki/moncef_Slaoui

 

EcohealthAlliance/darpa/NIH/Peter Daszak

https://en.wikipedia.org/wiki/Peter_Daszak

 

UNC-Chapel Hill & Wuhan's Ralph Baric

https://en.wikipedia.org/wiki/ralph_S._baric

 

Don't forget, the ONLY person to be arrested in any relation to Covid is Harvard and Wuhan's Charles Lieber- a man with 24 publicly viewable patents in NANOTECHNOLOGY.

 

______

Would nanotech (wetware) + 5G/starlink/solar cyclical ejections= Pandemic X?

 

Recall elon musk owns TWO wetware companies- nueralink and curevac (a tesla held mrna printing company),as well as Starlink…